
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery Platform
Sponsor : Maxymune Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration
Scipher and Maxymune Announce Collaboration to Accelerate Target Discovery
Details : Maxymune will leverage Scipher’s platform to capitalize on Scipher’s target ranking capabilities across research and development programs.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
September 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery Platform
Sponsor : Maxymune Therapeutics
Deal Size : Undisclosed
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Discovery Platform
Sponsor : Ionis Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Scipher Medicine Signs Multi-Target Partnership with Ionis
Details : Under the collaboration, Ionis will be responsible for advancing, developing and commercializing oligonucleotide therapies directed to targets discovered by Scipher’s Spectra™ platform.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
July 17, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Discovery Platform
Sponsor : Ionis Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Study Phase : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Collaboration
Scipher Medicine and Galapagos Sign Collaboration in Inflammatory Bowel Disease
Details : Scipher and Galapagos will jointly validate a suite of novel IBD targets discovered by Scipher after which Galapagos has the exclusive option to progress up to five targets into further drug discovery and development.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 12, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Highest Development Status : Discovery
Sponsor : Galapagos
Deal Size : Undisclosed
Deal Type : Collaboration
